Scandinavian Biopharma welcomes Dilek Merdol as new head of Quality Control (QC)

Scandinavian Biopharma continues to expand and has now recruited Dilek Merdol as new head of QC. Dilek has a PhD in infectious biology and has 20 years’ experience in R&D and laboratory operations. She comes from a position as manager in the unit of ​​Clinical Microbiology at Karolinska University Laboratory. “I am looking forward to […]

Scandinavian Biopharma announces the last follow up visit in the phase IIB clinical trial with ETVAX® in Finnish travellers to Benin

In record time Scandinavian Biopharma completed a phase IIB randomized, double-blind, placebo-controlled trial in Finnish travellers going to Benin in West Africa. All participants have now been enrolled and the last travellers left Benin in March 2019. The last follow up visit was conducted just before Easter. In total 743 healthy travellers, between the ages […]

Scandinavian Biopharma officially starts their late phase development program in Africa funded by EDCTP

The Permanent Secretary at Ministry of Health Dr Kennedy Malama together with the Swedish Ambassador Henrik Cederin, Dr Izukanji Sikazwe CEO at Centre for Infectious Disease Research in Zambia (CIDRZ) and Dr Godfrey Biemba CEO at National Health Research Authority (NHRA) in Zambia officially announced April 17th the start of Scandinavian Biopharma’s late phase paediatric […]

Scandinavian Biopharma recruits Madelene Franzén as Accounting Manager

Scandinavian Biopharma continues to expand and now welcomes Madelene Franzén as Accounting Manager. Madelene has previously been an authorized accounting consultant and will be responsible for Scandinavian Biopharma’s accounts. Madelene most recently comes from Björn Borg AB, where she worked as Senior Accountant. Madelene has also worked as an authorized accounting consultant for Wahlgren’s book-keeping […]

Scandinavian Biopharma has been awarded 7.4 million EUR from the EU for clinical trials of ETVAX® – a unique and newly developed vaccine against diarrheal disease

In international competition Scandinavian Biopharma has been awarded a grant of 7,4 million Euro for clinical trials of the ETEC vaccine ETVAX®.  The clinical trials will be conducted in the African countries Zambia and The Gambia. The newly developed vaccine ETVAX® targets diarrhea caused by ETEC – an enteric bacteria responsible for hundred thousands of […]



Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.